No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Canada Markets closed
Catalyst Biosciences, Inc. (CBIO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
695 reactions on $CBIO conversation
Sign in to post a message.
traded up over $1 on activist investor Julian Singer getting more active
then got caught up in market sell off
after a brief consolidation here should trade up sharply
Will buy at 60 cents...
Activist investor in, very good!
I bet Company Will be asked ti liquidate or merge
Catalysts, potential milestones, net cash twice pps, Easy double imo
Somebody’s keeping this stock from pink sheeting??
PROTUNE™ trademark registration is intended to cover the categories of licensing of intellectual property; licensing of intellectual property in the field of hematology, biochemical processes in the blood, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases.
Sell before it really dives. No future with company. Management should be investigated￼
I was looking to see who the top institutional investors were and OrbiMed is at the top of the list. It's funny though because Catalyst isn't shown on their webpage. I wonder if they sold out or are too embarrassed to show Catalyst as one of their holdings.
I Don’t mind what company does. but I bought this based on the following. I did opposite to what almost everyone did. they sold and I bought for a little discount. just 1000 shares not a big deal that much i can tolerate. right folks?
They have the cash to survive
More cash per share than share price
In with a small position
Good time to buy..dirt cheap, innovative platform and hopefully new management coming!
Why is the earnings call keep changing?? The market hates uncertainty! New management, PLEASE!
Well the only good thing is that, like the Titanic, the big institutional investors are not going to be able to abandon ship and are going down with the rest of us.
CBIO Will sell its clinical assets for cash, to add too current cash position that Is huge, Easy low float ready for a double
Over 2,5 when asset sale completed and Will be Ideal takeover or rm target
Their mistake was to make their announcement during tax loss period.
Third Quarter 2021 Results and Financial Highlights:
Cash, cash equivalents and, investments, as of September 30, 2021 were $64.5 million.
Enough money for the development of a new drug
Some investors use analyst ratings to stay informed about their investments. Analysts have changed their ratings for one or more companies in which you hold positions.
The following table displays the affected companies, the current number of analysts by rating category and, in parentheses, the recent change in the number of analysts rating the company within each rating category.
Symbol Buy Outperform Hold Underperform Sell Account(s)
CBIO@NASDAQ 0(-1) 3(0) 2(+1) 0(0) 0(0) U****254
Note: Current ratings are from Reuters and may not reflect all rating changes from other sources such as Street Insider and Briefing.
HEAT MUST BE GREAT NEWS FROM Interactive Brokers
To unsubscribe from this IBFYI, please click here or modify settings in TWS using the FYI button in Mosaic or in Client Portal via the FYI menu.
I can see the remains of this “company” swirling around in the toilet bowl. Glad I got out a couple reverse splits ago.
They still seem to make some money.
And it is as if they want to be
bought by a bigger company.
Goldman Sachs invests US$250,000,000 in Canadian underground battery firm
Yahoo Finance Canada
Repayment deadline for CEBA loans extended by Ottawa
Yahoo Finance Canada
Why I’d Choose Enbridge (TSX:ENB) Over an Energy ETF in 2022
The Motley Fool
© 2022 Yahoo
About Our Ads